How do growth hormone secretagogues like CJC-1295, Ipamorelin, and Sermorelin work differently to optimize GH levels?

CJC-1295, a GHRH analog, extends the half-life of growth hormone-releasing hormone, providing a sustained GH elevation. Ipamorelin, a GHRP, selectively stimulates GH release from the pituitary without impacting cortisol or prolactin, offering the cleanest profile. Sermorelin, another GHRH analog, is FDA-studied and aims to restore the pituitary's natural GH pulsatility, mimicking physiological release as Dr. Kyle Gillett suggests.

Can peptides like Gonadorelin and Kisspeptin-10 truly stimulate natural testosterone production, and how does this compare to synthetic approaches?

Yes, Gonadorelin and Kisspeptin-10 activate the Hypothalamic-Pituitary-Gonadal (HPG) axis, stimulating the pituitary to release LH and FSH, which in turn signals the testes to produce testosterone. As Dr. Andrew Huberman notes, this approach offers actual stimulation of endogenous testosterone production while maintaining fertility, unlike exogenous testosterone or some boosters.

What is the recommended dosing protocol for combining CJC-1295 and Ipamorelin for synergistic growth hormone optimization?

For optimal synergy, CJC-1295 (with DAC) is typically dosed at 2mg weekly or 1mg twice a week to provide a sustained background GH-releasing signal. Ipamorelin is then administered at 100-300mcg before bed, leveraging its selective GH release to create a more robust, physiological pulse.

Which specific blood markers should be monitored to assess the effectiveness of growth hormone peptides like CJC-1295 and Ipamorelin?

When optimizing growth hormone with peptides, key blood markers to monitor include IGF-1, aiming for an optimal range of 150-250 ng/mL, and Growth Hormone itself, observing a pulsatile release pattern between 0.5-3 ng/mL. These markers directly reflect the pituitary's response and the liver's production of growth factors.

How can peptides support women's hormonal health, particularly during the perimenopausal or menopausal transition?

Peptides offer a promising avenue for supporting the 'systems-level reorganization' women experience during perimenopause. As Dr. Sara Gottfried highlights, they can help optimize foundational aspects like sleep, mood, and cognition, which are often disrupted as hormone levels shift, contributing to overall quality of life.

PeptideKey Guides

Complete Guide: How Hormone Peptides Really Work [2026]

CJC-1295, ipamorelin, sermorelin, and other hormone-targeting peptides compared. GH secretagogues, testosterone support, and thyroid peptides explained.

This page is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.